Philip Morris International Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $42.5B+12.3% YoYTTM through 30 Jun 2026
Net Income $10.9B+54.1% YoYTTM through 30 Jun 2026
Free Cash Flow $12.7BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 67.5% |
| EBITDA Margin | 42.6% |
| Operating Margin | 37.7% |
| Net Margin | 25.6% |
Returns
-126.7%ROE
15.9%ROA
31.6%ROIC
Balance Sheet Health
Debt / Equity-5.71x
Current Ratio0.98x
Net Debt$43B
Cash & Equivalents$6B
Quality Metrics
Altman Z-Score4.50
Piotroski F-Score7 / 9
FCF Margin29.9%
Rule of 4032.0
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $40.6B
Diluted EPS$6.95TTMFY2025: $7.26
Dividend
$4.41Per share, FY20262.32%Yield1 yrsStreak-2.1%5-yr growth
Capital Allocation
R&D Spend$756M
Capex Intensity3.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Europe | $17.1B | +11.4% | |
| SSEA, CIS & MEA | $12.1B | +7.0% | |
| EA, AU & PMI GTR | $6.6B | ||
| Americas | $4.9B | +7.1% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.